Pulse Biosciences (PLSE) Net Cash Flow Growth (1y) (2016 - 2025)
Pulse Biosciences (PLSE) Net Cash Flow Growth (1y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 124.80 Bn | 119.58 Bn | 1.96 Bn | -9.88% |
| 2 | Becton Dickinson | 44.47 Bn | 43.65 Bn | 2.15 Bn | 131.47% |
| 3 | Alcon | 33.17 Bn | 31.51 Bn | 1.53 Bn | - |
| 4 | Medline | 32.67 Bn | 30.44 Bn | 1.84 Bn | -47.85% |
| 5 | Resmed | 29.06 Bn | 27.40 Bn | 890.98 Mn | -40.20% |
| 6 | West Pharmaceutical Services | 23.50 Bn | 23.06 Bn | 329.20 Mn | -196.55% |
| 7 | Solventum | 13.91 Bn | 13.35 Bn | 1.10 Bn | -41.07% |
| 8 | Cooper Companies | 13.82 Bn | 13.68 Bn | 735.40 Mn | 102.38% |
| 9 | Align Technology | 12.13 Bn | 11.07 Bn | 736.59 Mn | 84.02% |
| 10 | Pulse Biosciences | 2.11 Bn | 2.03 Bn | - | -137.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -137.12% |
| Sep 30, 2025 | -121.07% |
| Jun 30, 2025 | -48.81% |
| Mar 31, 2025 | 113.09% |
| Dec 31, 2024 | 747.82% |
| Sep 30, 2024 | 731.95% |
| Jun 30, 2024 | -286.90% |
| Mar 31, 2024 | -34.64% |
| Dec 31, 2023 | 24.95% |
| Sep 30, 2023 | -115.38% |
| Jun 30, 2023 | 119.09% |
| Mar 31, 2023 | 55.82% |
| Dec 31, 2022 | 40.02% |
| Sep 30, 2022 | 1,100.26% |
| Jun 30, 2022 | 117.03% |
| Mar 31, 2022 | -133.61% |
| Dec 31, 2021 | -348.04% |
| Sep 30, 2021 | 82.29% |
| Jun 30, 2021 | -141.66% |
| Mar 31, 2021 | 4,813.99% |